Home

RxSight, Inc. - Common Stock (RXST)

33.87
+1.01 (3.07%)

Rxsight Inc is a healthcare technology company that focuses on enhancing vision correction through its innovative approach to personalized refractive surgery

The company develops advanced systems that utilize sophisticated algorithms and proprietary software to optimize intraocular lenses for patients undergoing cataract surgery. By combining data-driven insights with precision eye care, Rxsight aims to improve visual outcomes for patients, ultimately advancing the standards of treatment in the ophthalmic field. Their commitment to personalized medicine is reflected in their ongoing research and development efforts to create more effective solutions for vision-related challenges.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close32.86
Open33.00
Bid33.75
Ask34.18
Day's Range32.65 - 34.53
52 Week Range26.29 - 66.54
Volume662,347
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume674,203

News & Press Releases

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance
ALISO VIEJO, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQRXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the fourth quarter and full-year 2024 and provided full-year 2025 guidance.
By RxSight, Inc. · Via GlobeNewswire · January 12, 2025
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
ALISO VIEJO, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQRXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference.
By RxSight, Inc. · Via GlobeNewswire · January 2, 2025
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Fridaybenzinga.com
Via Benzinga · December 20, 2024
Forecasting The Future: 4 Analyst Projections For RxSightbenzinga.com
Via Benzinga · December 20, 2024
Analyst Scoreboard: 7 Ratings For RxSightbenzinga.com
Via Benzinga · October 29, 2024
Peeling Back The Layers: Exploring RxSight Through Analyst Insightsbenzinga.com
Via Benzinga · September 13, 2024
Deep Dive Into RxSight Stock: Analyst Perspectives (6 Ratings)benzinga.com
Via Benzinga · August 6, 2024
RxSight Analysts Slash Their Forecasts After Q2 Resultsbenzinga.com
Via Benzinga · August 6, 2024
Visa To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesdaybenzinga.com
Via Benzinga · December 11, 2024
RxSight, Inc. Reports Third Quarter 2024 Financial Results
ALISO VIEJO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- (NASDAQRXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended September 30, 2024.
By RxSight, Inc. · Via GlobeNewswire · November 7, 2024
This Six Flags Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesdaybenzinga.com
Via Benzinga · October 29, 2024
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
ALISO VIEJO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the third quarter of 2024 after the market close on Thursday, November 7, 2024. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
By RxSight, Inc. · Via GlobeNewswire · October 24, 2024
RXST Stock Earnings: RxSight Beats Revenue for Q2 2024investorplace.com
RXST stock results show that RxSight beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 5, 2024
RxSight Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)benzinga.com
Via Benzinga · July 15, 2024
RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
ALISO VIEJO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQRXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced its plans to participate in two upcoming healthcare conferences in September.
By RxSight, Inc. · Via GlobeNewswire · August 22, 2024
RxSight Stock Sees Relative Strength Rating Rise To 91investors.com
On Monday, RxSight stock earned a positive adjustment to its Relative Strength (RS) Rating, from 88 to 91.
Via Investor's Business Daily · August 19, 2024
Lithia Motors To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesdaybenzinga.com
Via Benzinga · August 6, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesdayinvestorplace.com
We have all of the biggest pre-market stock movers that traders are going to want to read about on Tuesday!
Via InvestorPlace · August 6, 2024
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · August 6, 2024
The 3 Best Med Tech Stocks to Buy Nowinvestorplace.com
Med tech firms are tremendously improving healthcare and making a great deal of money. Here are the three best med tech stocks to buy now.
Via InvestorPlace · August 5, 2024
RxSight, Inc. Reports Second Quarter 2024 Financial Results
ALISO VIEJO, Calif., Aug. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQRXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today reported financial results for the three months ended June 30, 2024.
By RxSight, Inc. · Via GlobeNewswire · August 5, 2024
RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
ALISO VIEJO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQRXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the second quarter of 2024 after the market close on Monday, August 5, 2024. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
By RxSight, Inc. · Via GlobeNewswire · July 22, 2024
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?benzinga.com
Johnson & Johnson has beaten earnings per share in more than 10 straight quarters. Will the trend continue in Q2?
Via Benzinga · July 16, 2024
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Via Benzinga · July 10, 2024
RxSight, Inc. To Participate in the Truist Securities Medtech Conference
ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Truist Securities MedTech Conference.
By RxSight, Inc. · Via GlobeNewswire · June 5, 2024